Details of Host Protein
Host Protein General Information (ID: PT0424) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Protein Name |
Exosome complex component MTR3 (PRRC2A)
|
Gene Name |
EXOSC6
|
||||||
Host Species |
Homo sapiens
|
Uniprot Entry Name |
EXOS6_HUMAN
|
||||||
Protein Families |
RNase PH family
|
||||||||
Subcellular Location |
Cytoplasm Nucleus; nucleolus Nucleus
|
||||||||
External Link | |||||||||
NCBI Gene ID | |||||||||
Uniprot ID | |||||||||
Ensembl ID | |||||||||
HGNC ID | |||||||||
Function in Host |
Non-catalytic component of the RNA exosome complex which has3'->5' exoribonuclease activity and participates in a multitude ofcellular RNA processing and degradation events. In the nucleus, the RNAexosome complex is involved in proper maturation of stable RNA speciessuch as rRNA, snRNA and snoRNA, in the elimination of RNA processingby-products and non-coding 'pervasive' transcripts, such as antisenseRNA species and promoter-upstream transcripts (PROMPTs), and of mRNAswith processing defects, thereby limiting or excluding their export tothe cytoplasm. The RNA exosome may be involved in Ig class switchrecombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNAsubstrates. In the cytoplasm, the RNA exosome complex is involved ingeneral mRNA turnover and specifically degrades inherently unstablemRNAs containing AU-rich elements (AREs) within their 3' untranslatedregions, and in RNA surveillance pathways, preventing translation ofaberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation ofRNA for ribonucleolysis, and to serve as a scaffold for the associationwith catalytic subunits and accessory proteins or complexes.
[1]
Click to Show/Hide
|
||||||||
Related KEGG Pathway | |||||||||
RNA degradation | hsa03018 |
Pathway Map ![]() |
|||||||
3D Structure |
|
Function of This Protein During Virus Infection | |||||||||
---|---|---|---|---|---|---|---|---|---|
Virus Name | SARS-COV-2 | Protein Function | Anti-viral | [2] | |||||
Infected Tissue | Lung | Infection Time | 7-9 Days | ||||||
Infected Cell | Calu-3 Cells (Human epithelial cell line) | Cellosaurus ID | CVCL_0609 | ||||||
Method Description | To detect the role of host protein EXOSC6 in viral infection, EXOSC6 protein knockout Calu-3 Cells were infected with SARS-COV-2 for 7 - 9 Days , and the effects on infection was detected through CRISPR-based genome-wide gene-knockout screen. | ||||||||
Results | It is reported that knockout of EXOSC6 increases SARS-CoV-2 RNA levels compared with control group. |
Full List of Virus RNA Interacting with This Protien | |||||||||
---|---|---|---|---|---|---|---|---|---|
RNA Region: ORF10 (hCoV-19/Not Specified Virus Strain ) | |||||||||
RNA Region Details |
RNA Info
![]() |
[3] | |||||||
Strains Name |
hCoV-19/Not Specified Virus Strain
|
||||||||
RNA Binding Region |
ORF10
|
||||||||
Virus Name |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
|
||||||||
Infection Cells | Calu-3 cells (Human Lung Cancer Cell) (CVCL_0609 ) | ||||||||
Cell Originated Tissue | Liver | ||||||||
Interaction Score | P-value < 0.05 | ||||||||
Method Description | RNA pull-down assays; liquid chromatography with tandem mass spectrometry (LC-MS/MS); Wilcoxon test; MS2 affinity purification coupled with liquid chromatography-mass spectrometry (MAMS) |